| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.29 | 3e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |